DNA Methylation Changes during In Vitro Propagation of Human Mesenchymal Stem Cells: Implications for Their Genomic Stability?

被引:41
作者
Bentivegna, Angela [1 ]
Miloso, Mariarosaria [1 ]
Riva, Gabriele [1 ]
Foudah, Dana [1 ]
Butta, Valentina [1 ]
Dalpra, Leda [1 ]
Tredici, Giovanni [1 ]
机构
[1] Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, I-20900 Monza, Italy
关键词
HUMAN BONE-MARROW; SPONTANEOUS MALIGNANT-TRANSFORMATION; LONG-TERM CULTURE; STROMAL CELLS; LIFE-SPAN; CROSS-CONTAMINATION; CELLULAR SENESCENCE; TELOMERASE ACTIVITY; DOWN-REGULATION; PROLIFERATION;
D O I
10.1155/2013/192425
中图分类号
Q813 [细胞工程];
学科分类号
100113 [医学细胞生物学];
摘要
Mesenchymal stemcells (MSCs) hold great promise for the treatment of numerous diseases. A major problem for MSC therapeutic use is represented by the very low amount of MSCs which can be isolated from different tissues; thus ex vivo expansion is indispensable. Long-term culture, however, is associated with extensive morphological and functional changes of MSCs. In addition, the concern that they may accumulate stochastic mutations which lead the risk of malignant transformation still remains. Overall, the genome of human MSCs (hMSCs) appears to be apparently stable throughout culture, though transient clonal aneuploidies have been detected. Particular attention should be given to the use of low-oxygen environment in order to increase the proliferative capacity of hMSCs, since data on the effect of hypoxic culture conditions on genomic stability are few and contradictory. Furthermore, specific and reproducible epigenetic changes were acquired by hMSCs during ex vivo expansion, which may be connected and trigger all the biological changes observed. In this review we address current issues on long-term culture of hMSCs with a 360-degree view, starting from the genomic profiles and back, looking for an epigenetic interpretation of their genetic stability.
引用
收藏
页数:9
相关论文
共 94 条
[1]
Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung [J].
Aguilar, Susana ;
Nye, Emma ;
Chan, Jerry ;
Loebinger, Michael ;
Spencer-Dene, Bradley ;
Fisk, Nick ;
Stamp, Gordon ;
Bonnet, Dominique ;
Janes, Sam M. .
STEM CELLS, 2007, 25 (06) :1586-1594
[2]
Common fragile sites as targets for chromosome rearrangements [J].
Arlt, Martin F. ;
Durkin, Sandra G. ;
Ragland, Ryan L. ;
Glover, Thomas W. .
DNA REPAIR, 2006, 5 (9-10) :1126-1135
[3]
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].
Banfi, A ;
Muraglia, A ;
Dozin, B ;
Mastrogiacomo, M ;
Cancedda, R ;
Quarto, R .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715
[4]
Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells [J].
Barrand, Sanna ;
Collas, Philippe .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) :762-767
[5]
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[6]
Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status [J].
Basciano, Leticia ;
Nemos, Christophe ;
Foliguet, Bernard ;
de Isla, Natalia ;
de Carvalho, Marcelo ;
Nguyen Tran ;
Dalloul, Ali .
BMC CELL BIOLOGY, 2011, 12
[7]
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion [J].
Baxter, MA ;
Wynn, RF ;
Jowitt, SN ;
Wraith, JE ;
Fairbairn, LJ ;
Bellantuono, I .
STEM CELLS, 2004, 22 (05) :675-682
[8]
Bcrdasco M., 2011, STEM CELL RES THERAP, V2
[9]
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry [J].
Berdasco, Maria ;
Esteller, Manel .
DEVELOPMENTAL CELL, 2010, 19 (05) :698-711
[10]
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? [J].
Bernardo, M. E. ;
Pagliara, D. ;
Locatelli, F. .
BONE MARROW TRANSPLANTATION, 2012, 47 (02) :164-171